Drugs / lentiviral gene therapy
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04601974 | Sep 2024 → Sep 2028 expected | epilepsy | University College, London | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | lentiviral gene therapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04601974 ↗ |
| Route | Other | “will be administered via intracerebral infusion” NCT04601974 ↗ |